CME holder files Rule 144 to sell 748 shares

CME Group has a holder filing a notice under Rule 144 to sell up to 748 shares of Class A common stock through J.P.

Accepted by SEC EDGAR 02/06/2026 - 04:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CME Group has a holder filing a notice under Rule 144 to sell up to 748 shares of Class A common stock through J.P. Morgan Securities on the NASDAQ around 02/06/2026. Shares outstanding were 360,596,647, indicating this is a very small potential sale relative to the total.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CME Form 144 filing disclose?

The filing discloses a planned sale under Rule 144 of 748 shares of CME Group Class A common stock. The shares may be sold through J.P. Morgan Securities on the NASDAQ around February 6, 2026, subject to market conditions and Rule 144 requirements.

How many CME Group shares are planned to be sold under this Form 144?

The notice covers a potential sale of 748 shares of CME Group Class A common stock. This amount is small compared with the 360,596,647 shares outstanding, but still must be reported because Rule 144 requires advance notice for certain holders and transaction sizes.

When and how were the CME shares in the Form 144 acquired?

The 748 CME Group Class A shares were acquired on October 9, 2024, as compensation from the issuer. Both the acquisition date and the nature of the transaction are disclosed, indicating these shares were granted rather than purchased for cash in the market.

Which broker and exchange are listed for the CME Form 144 sale?

The filing lists J.P. Morgan Securities LLC, based at 270 Park Avenue in New York, as the broker. The intended marketplace for the 748-share sale is the NASDAQ exchange, providing transparency into how and where the potential transaction may occur.

How large is this CME Form 144 sale compared to shares outstanding?

The Form 144 covers 748 shares versus 360,596,647 CME Group Class A shares outstanding. This makes the proposed sale very small relative to the total share count, though Rule 144 still requires notice from certain holders even for modest transactions like this.

What is the nature of payment for the CME shares being sold?

The 748 CME Group shares were received as compensation from the issuer on October 9, 2024, and are described as compensation in both the acquisition and payment fields. This indicates they were granted as part of a compensation arrangement rather than bought with cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001361519
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CME Group, Inc.
SEC File Number	001-31553
Address of Issuer	20 South Wacker Drive Chicago ILLINOIS 60606
Phone	312-930-1000
Name of Person for Whose Account the Securities are To Be Sold	Dennis Suskind
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	748	222440	360596647	02/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	10/09/2024	Compensation	Issuer			748	10/09/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Dennis Suskind
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)